ReviewFrontiers in oncology2017

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib.

Sami Morin-Ben Abdallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.